178 related articles for article (PubMed ID: 22565000)
1. Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?
Martin M; Marais R
J Clin Oncol; 2012 Jul; 30(21):2698-700. PubMed ID: 22565000
[No Abstract] [Full Text] [Related]
2. Cracking open window of opportunity trials.
Kalinsky K; Hershman DL
J Clin Oncol; 2012 Jul; 30(21):2573-5. PubMed ID: 22565006
[No Abstract] [Full Text] [Related]
3. Metformin as an addition to conventional chemotherapy in breast cancer.
Grenader T; Goldberg A; Shavit L
J Clin Oncol; 2009 Dec; 27(35):e259; author reply e260. PubMed ID: 19884518
[No Abstract] [Full Text] [Related]
4. Metformin and pancreatic cancer: a clue requiring investigation.
Pollak M
Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
[TBL] [Abstract][Full Text] [Related]
5. Metformin in breast cancer: time for action.
Goodwin PJ; Ligibel JA; Stambolic V
J Clin Oncol; 2009 Jul; 27(20):3271-3. PubMed ID: 19487373
[No Abstract] [Full Text] [Related]
6. [Anti-oncogenic effect of metformin].
Noto H
Nihon Rinsho; 2016 Apr; 74 Suppl 2():693-6. PubMed ID: 27266176
[No Abstract] [Full Text] [Related]
7. Cancer protection.
Harv Health Lett; 2005 Oct; 30(12):7. PubMed ID: 16278981
[No Abstract] [Full Text] [Related]
8. Metformin and cancer therapy.
Bost F; Sahra IB; Le Marchand-Brustel Y; Tanti JF
Curr Opin Oncol; 2012 Jan; 24(1):103-8. PubMed ID: 22123231
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathways: preclinical models and clinical trials with metformin in breast cancer.
Thompson AM
Clin Cancer Res; 2014 May; 20(10):2508-15. PubMed ID: 24682417
[TBL] [Abstract][Full Text] [Related]
10. The role of AMPK/mTOR signaling pathway in anticancer activity of metformin.
Chomanicova N; Gazova A; Adamickova A; Valaskova S; Kyselovic J
Physiol Res; 2021 Aug; 70(4):501-508. PubMed ID: 34062070
[TBL] [Abstract][Full Text] [Related]
11. Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells.
Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Martin-Castillo B; Menendez JA
Curr Mol Med; 2010 Oct; 10(7):674-91. PubMed ID: 20712585
[TBL] [Abstract][Full Text] [Related]
12. Metformin, cancer and glucose metabolism.
Salani B; Del Rio A; Marini C; Sambuceti G; Cordera R; Maggi D
Endocr Relat Cancer; 2014; 21(6):R461-71. PubMed ID: 25273809
[TBL] [Abstract][Full Text] [Related]
13. Metformin: "Old warrior for a new battle".
Jain A
Indian J Cancer; 2010; 47(4):471-2. PubMed ID: 21131766
[No Abstract] [Full Text] [Related]
14. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
[TBL] [Abstract][Full Text] [Related]
15. Metformin, B(12), and enhanced breast cancer response to chemotherapy.
Garcia A; Tisman G
J Clin Oncol; 2010 Jan; 28(2):e19; author reply e20. PubMed ID: 19949002
[No Abstract] [Full Text] [Related]
16. Metformin targets multiple signaling pathways in cancer.
Lei Y; Yi Y; Liu Y; Liu X; Keller ET; Qian CN; Zhang J; Lu Y
Chin J Cancer; 2017 Jan; 36(1):17. PubMed ID: 28126011
[TBL] [Abstract][Full Text] [Related]
17. Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.
Pusceddu S; Buzzoni R; Vernieri C; Concas L; Marceglia S; Giacomelli L; Milione M; Leuzzi L; Femia D; Formisano B; Mazzaferro V; de Braud F
Future Oncol; 2016 May; 12(10):1251-60. PubMed ID: 26890290
[TBL] [Abstract][Full Text] [Related]
18. Metformin: a new option in cancer treatment.
Belda-Iniesta C; Pernía O; Simó R
Clin Transl Oncol; 2011 Jun; 13(6):363-7. PubMed ID: 21680296
[TBL] [Abstract][Full Text] [Related]
19. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.
Jiralerspong S; Palla SL; Giordano SH; Meric-Bernstam F; Liedtke C; Barnett CM; Hsu L; Hung MC; Hortobagyi GN; Gonzalez-Angulo AM
J Clin Oncol; 2009 Jul; 27(20):3297-302. PubMed ID: 19487376
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer. Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer.
Greenhill C
Nat Rev Gastroenterol Hepatol; 2015 Mar; 12(3):124. PubMed ID: 25623201
[No Abstract] [Full Text] [Related]
[Next] [New Search]
